51 results match your criteria: "CKD Research Institute[Affiliation]"
Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative.
Ann N Y Acad Sci
February 2001
CKD Research Institute, CKD Pharmaceutical Corporation, Seoul 152-600, Korea.